Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term ibuprofen and urinary NGAL in primary dysmenorrhea
IRCT20191205045614N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of ibuprofen in primary dysmenorrhea (PD) (2 arms), sponsored by Islamic Azad University. Primary endpoint: Change in neutrophil gelatinase-associated lipocalin biomarker level. Started May 2020; status: completed.
02
Drugs
ibuprofen
03
Conditions
primary dysmenorrhea (PD)
Beyond the preview
Go deeper on IRCT20191205045614N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191205045614N1.